<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04322422</url>
  </required_header>
  <id_info>
    <org_study_id>CTVA-ZJU</org_study_id>
    <nct_id>NCT04322422</nct_id>
  </id_info>
  <brief_title>Clinical Characteristics and Treatment of Chest Tightness Variant Asthma</brief_title>
  <official_title>Clinical Characteristics and Treatment of Chest Tightness Variant Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asthma, abbreviation for bronchial asthma, is one of the common chronic airways disease that
      threatens human health. Typical symptoms of asthma are recurrent wheezing, shortness of
      breath, chest tightness and cough, usually occurring at night or early morning. However,
      there are still some patients with only persistent clinical manifestations of chest
      tightness. Concerned about this group of patients, investigators presented a subgroup of
      bronchial asthma, namely, chest tightness variant asthma (CTVA). This asthma subgroup usually
      lacks asthma-specific clinical features such as wheezing, shortness of breath, wheezing, and
      therefore often misdiagnosed for a long time. However, there is lack of definite treatment
      strategy for CTVA. In order to further understand the clinical characteristics and treatment
      of patients with CTVA, investigators conducted a national multicenter randomized control
      trial(RCT) study that compares inhaled corticosteroid(ICS)/ long-acting beta2-agonist(LABA) +
      Montelukast with ICS/LABA. Finally, investigators plan to clarify whether ICS/LABA plus
      Montelukast is more appropriate treatment than only ICS/LABA in CTVA patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Asthma control questionnaire (ACQ)</measure>
    <time_frame>Change from baseline intervention therapy at 3 months</time_frame>
    <description>Scores of asthma control questionnaire (ACQ)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Forced expiratory volume in one second</measure>
    <time_frame>Change from baseline intervention therapy at 3 months</time_frame>
    <description>Value of forced expiratory volume in one second</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Airway responsiveness</measure>
    <time_frame>Change from baseline intervention therapy at 3 months</time_frame>
    <description>Value of airway responsiveness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak expiratory flow</measure>
    <time_frame>Change from baseline intervention therapy at 3 months</time_frame>
    <description>Value of peak expiratory flow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma quality of life questionnaire</measure>
    <time_frame>Change from baseline intervention therapy at 3 months</time_frame>
    <description>Scores of asthma quality of life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute asthma episode</measure>
    <time_frame>Change from baseline intervention therapy at 3 months</time_frame>
    <description>Numbers of acute asthma episode</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numbers of emergency or hospitalization</measure>
    <time_frame>Change from baseline intervention therapy at 3 months</time_frame>
    <description>Numbers of emergency or hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Asthma</condition>
  <condition>Chest Syndrome</condition>
  <condition>Clinical Anxiety</condition>
  <condition>Clinical Depression</condition>
  <condition>Lung Function</condition>
  <condition>Quality of Life</condition>
  <condition>Eosinophilia</condition>
  <condition>Nitric Oxide</condition>
  <condition>Airway Responsiveness</condition>
  <condition>Induced Sputum</condition>
  <arm_group>
    <arm_group_label>ICS/LABA plus Montelukast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ICS/LABA only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhaled corticosteriod/long-acting beta-agonist plus Montelukast</intervention_name>
    <description>Inhaled corticosteriod/long-acting beta-agonist are regular inhaled drugs for classic asthma; Montelukast is benefitial for allergic disease</description>
    <arm_group_label>ICS/LABA plus Montelukast</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhaled corticosteriod/long-acting beta-agonist only</intervention_name>
    <description>Inhaled corticosteriod/long-acting beta-agonist are regular inhaled drugs for classic asthma</description>
    <arm_group_label>ICS/LABA only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. all subjects agreed to participate, understand the project, observe the use of drugs,
             agree to follow-up, and signed informed consent;

          2. the age of more than 14 and less 80 years old, gender and ethnicity are not limited;

          3. the duration time was more than 6 months,and chest tightness was the only complaint,
             without breathing, short of breath, chronic cough;

          4. no wheezing;

          5. a diagnosis of asthma supported by one or more other characteristics:

               -  bronchial provocation test positive;

               -  improvement in forced expiratory volume at one second (FEV1) of more than 12% and
                  200 mL after inhaled salbutamol;

               -  variability in diurnal peak expiratory flow (PEF) of more than 10% for one day
                  during one week.

          6. bronchodilator and glucocorticoid treatment is effective;

          7. exclude the following diseases by the corresponding doctors: coronary heart disease,
             myocarditis, heart failure, gastroesophageal reflux disease(GERD), neuromuscular
             disease, and mental disease.

        Exclusion Criteria:

          1. can not cooperate with related inspection or for other reasons;

          2. patients with chronic obstructive pulmonary disease, interstitial pneumonia, active
             tuberculosis, community acquired pneumonia, lung cancer, bronchiectasis, cor
             pulmonale, pulmonary embolism, and accompanied with serious systematic disease (such
             as coronary heart disease, myocarditis, heart failure, gastroesophageal reflux
             disease, neuromuscular disease, etc);

          3. history of drug abuse, alcohol abuse or anesthesia or with a history of mental illness
             (schizophrenia, obsessive-compulsive disorder, depression) and against personality,
             motivation, suspicious, or other emotional or mental issues that may affect
             participation in the study;

          4. taking part in other drug clinical trial project, or drop out less than 3 months;

          5. during pregnancy, lactation women;

          6. obvious abnormal of High Resolution CT.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>fugui Yan</last_name>
    <phone>13757158676</phone>
    <email>yfg0726@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Huahao Shen</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Chao-Yang Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>China-Japan Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Xinqiao Hospital，Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital，Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nanfang Hospital, Nanfang Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital,Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nanshan Zhong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Shenzhen</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital,Zhanjiang Medical College</name>
      <address>
        <city>Zhanjiang</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Guizhou Provincial People's Hospital</name>
      <address>
        <city>Guiyang</city>
        <state>Guizhou</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Henan Provincial People's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Second Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jiangsu Province Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Central Hospital of Shenyang Military</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital, China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Qilu Hospital, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shandong Provincal Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Qingdao Municipal Hospital</name>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Weifang Asthma Hospital</name>
      <address>
        <city>Weifang</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yantai liuhuanding Hospital</name>
      <address>
        <city>Yantai</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Changhai Hospital, Second Military Medical University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>No.1 Hospital, Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ruijin Hospital, Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital, Tongji University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Xinhua Hospital, Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>West China Hospital，Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Second Affiliated Hospital, School of Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fugui Yan</last_name>
      <email>yfg0726@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sir Run Run Shaw hospital, College of Medicine，Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Huzhou Central Hospital</name>
      <address>
        <city>Huzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital,Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 24, 2020</study_first_submitted>
  <study_first_submitted_qc>March 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2020</study_first_posted>
  <last_update_submitted>May 10, 2020</last_update_submitted>
  <last_update_submitted_qc>May 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Eosinophilia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Montelukast</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

